靶点针对疾病信息20(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
TARGNAME
Cannabinoid receptor 2 (CB2)
INDICATI
Approved Attention deficit hyperactivity disorder [ICD-11: 6A05]
INDICATI
Approved Insomnia [ICD-11: 7A00-7A0Z]
INDICATI
Phase 2 Atopic eczema [ICD-11: EA80]
INDICATI
Phase 2 General pain disorder [ICD-11: 8E43]
INDICATI
Phase 2 Inborn lipid metabolism error [ICD-11: 5C52]
INDICATI
Phase 2 Pain [ICD-11: MG30-MG3Z]
INDICATI
Patented Endometriosis [ICD-11: GA10]
INDICATI
Patented Low bone mass disorder [ICD-11: FB83]
INDICATI
Patented Prostate cancer [ICD-11: 2C82]
INDICATI
Discontinued in Phase 1 Cerebral ischaemia [ICD-11: 8B1Z]
INDICATI
Investigative Immune system disease [ICD-11: 4A01-4B41]
INDICATI
Investigative Postoperative inflammation [ICD-11: 1A00-CA43]